Three more years for Ethicon/Neoprobe distribution pact:
This article was originally published in Clinica
Executive Summary
Ethicon Endo-Surgery is to distribute Dublin, Ohio-based Neoprobe's neo2000 gamma detection system through to December 2008, following a renewal of the companies' existing contract. The Johnson & Johnson subsidiary has been worldwide distributor (except in Japan) of the system since 1999. The neo2000 is used for performing a sentinel lymph node biopsy (SLNB), which traces the lymphatic patterns in a cancer patient to assess potential tumour drainage and cancer spread in lymphatic tissue. The technique does not detect cancer but helps surgeons to identify the lymph nodes to which a tumour is likely to drain and spread.